Menopause Drug Receives FDA Black Box Warning for Risk of Severe Liver Injury

The AHA! Team — Mon, 23 Jun 2025 05:04:56 +0000

Stephanie Woods via NaturalHealth365 – Once again, Big Pharma is chasing the almighty dollar, treating the natural process of aging as a disease, and exposing women to serious injury while doing it. A “black box warning,” the U.S. Food and Drug Administration’s (FDA) most serious warning, has been placed on Veozah (fezolinetant), a drug marketed to menopausal women seeking relief from hot flashes. The drug became suspected of causing severe liver problems when a case was entered into the FDA Adverse Event Reporting System (FAERS) Database. Big Pharma’s latest menopause drug comes with a severe liver injury warning The details of the case entered into the FAERS database described a reaction to the drug that was characterized by symptoms that included nausea, yellow skin and eyes, fatigue, dark urine, itching, and light-colored stools. All of these point to serious liver injury. Within 40 days of the patient starting Veozah, the symptoms were very prominent. She experienced elevated liver blood test values and abnormal bilirubin and liver enzyme levels. Once she stopped taking the drug, her symptoms gradually decreased and eventually went away completely. Over time, her blood test values returned to normal as well. FDA downplays liver injury risks of Veozah while Big Pharma profits from side effects The FDA offered its standard response: “All medicines have side effects, even when used correctly as prescribed.” However, the agency failed to address the significant revenue generated from the serious side effects that benefit pharmaceutical companies. The liver injury in question was severe, requiring additional treatment with more medications to counteract the damage caused by the first drug. In Big Pharma’s world, even when they lose, they still win. FDA downplayed risks The FDA downplayed the risks by using carefully crafted language, emphasizing that liver injury is rare and individual medication responses vary. This made it impossible to predict whether others might suffer the same adverse effects. The agency issued new guidelines for healthcare professionals and patients, recommending more frequent liver blood tests while on Veozah. Patients should undergo testing once a month for the first two months and then at three, six, and nine months. If any signs of liver injury appear, patients are instructed to contact their healthcare provider immediately. Aging is not a curse Aging is a natural process, with the human body undergoing various changes as it adapts to shifting hormone levels and other factors. However, for Big Pharma, it’s an opportunity to profit. According to Medicare’s National Health Expenditure report, adults 65 and older spend more than five times the average on personal health care, reaching $22,356 in 2020. There is an overwhelming societal push to stay unnaturally young. The media constantly feeds us messages suggesting we’re never quite good enough and that as we age, we become irrelevant. Staying young has become synonymous with staying relevant. Sadly, many doctors buy into this narrative, promoting age-defying “remedies” that fuel the industry’s agenda. But aging is not a disease. Cut your risks of pharmaceutical injury with natural solutions There are several natural ways to reduce hot flashes without the harmful side effects that often come with pharmaceutical treatments. One study found that a plant-based, vegan diet rich in soy helped women reduce their hot flashes by 88%. This simple dietary change not only alleviates hot flashes but also eliminates the risk of harmful side effects associated with drugs. Other natural remedies, such as Dong Quai, black cohosh, and red clover, have also been shown to offer relief. Consult with your holistic healthcare provider about incorporating these natural menopause remedies into your routine instead of turning to drugs that can harm your body. The human body is an incredible machine that thrives when given the proper support. Nurture it with natural solutions, and it will serve you well. Editor’s note: Discover natural ways to detoxify the liver and avoid unwanted disease symptoms, own the Fatty Liver Docu-Class created by NaturalHealth365 Programs. Sources for this article include: FDA.gov CMS.gov FDA.gov To read the original article click here.

The post Menopause Drug Receives FDA Black Box Warning for Risk of Severe Liver Injury appeared first on Amazing Health Advances.

Experimental Treatment Offers Hope of Fertility for Early Menopausal Women

AHA Publisher — Fri, 02 Apr 2021 07:00:20 +0000

The North American Menopause Society (NAMS) via EurekAlert – Menopause typically signals the end of a woman’s ability to become pregnant. However, in a small new study, a novel approach of administering platelet-rich plasma and gonadotropins near the ovarian follicles is showing promise in restoring ovarian function. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). As more women look to build their careers before pursuing motherhood, the average age of conceiving a child continues to be pushed back. For some of these women, however, their hope of becoming pregnant is cut short by the onset of early menopause, which is described as the cessation of ovarian function at or before the age of 45 years. It is estimated that roughly 12.2% of women experience early menopause. For these women, the only chance of becoming pregnant is with donor eggs. Multiple treatment options have previously been investigated, including standard, controlled ovarian stimulation. Platelet-rich plasma has been used in women with primary ovarian insufficiency, but few pregnancies and live births resulted. With the failure of these somewhat traditional treatments, more novel approaches, such as methods for inducing the growth of ovarian follicles, are being pursued. In this new, small-scale pilot study, platelet-rich plasma and gonadotropins were injected into the ovaries of study participants, with some fairly amazing results. After treatment, 11 of the 12 study participants resumed menstruation, and one achieved clinical pregnancy, defined as a pregnancy that is confirmed by ultrasound as well as a fetal heartbeat. Although more research and larger studies are needed, these early results regarding the successful resumption of ovarian function offer hope to women in early menopause who may be able to pursue pregnancy through in vitro fertilization using their own eggs. Results are published in the article “Resumed ovarian function and pregnancy in early menopausal women by whole dimension subcortical ovarian administration of platelet-rich plasma and gonadotropins.” “This pilot study investigating the use of platelet-rich plasma and gonadotropins injected into the ovaries of women with early menopause highlights the promise of regenerative medicine in restoring or prolonging fertility. Additional studies conducted prospectively and involving large numbers of women are needed to determine whether this is truly a viable option for women with early menopause hoping to achieve pregnancy using their own eggs,” says Dr. Stephanie Faubion, NAMS medical director. To read the original article click here.

The post Experimental Treatment Offers Hope of Fertility for Early Menopausal Women appeared first on Amazing Health Advances.

early menopause Archives - Amazing Health Advances

Menopause Drug Receives FDA Black Box Warning for Risk of Severe Liver Injury

Experimental Treatment Offers Hope of Fertility for Early Menopausal Women